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Background
The human skeleton is the most common organ to be
affected by metastatic cancer (skeletal or bone metastases).
The prevalence of skeletal disease is greatest in breast and
prostate carcinoma. Bone metastases lesions weaken bone
structure, causing a range of symptoms and complications.
Sufferers of breast and prostate cancers may develop
Skeletal related events (SRE). These SRE are defined as
pain that require palliative radiotherapy or surgery to
bone, hypercalcaemia, pathologic fractures, spinal cord
compression and bone marrow failure. These complica-
tions contribute to a decline in patients’ HRQOL (health
related quality of life). However, information on treatment
costs of breast and prostate cancers and multidimensional
assessments of QOL are limited. Thus this study aim to
obtain both cost and QOL of breast and prostate cancers
patients and to determine their relationship with the
patients sociodemograhic profiles (age, ethnicity, income)
and disease profile (tumour types, cancer stages and SRE
status).
Objective
To determine the health care cost and QOL of breast and
prostate cancer patients in Malaysia. The association of
risk factors (sociodemographic and diseases profiles
including SRE status) and cost and QOL will later be
determined through statistical analysis.
Methodology
This will be a societal approach, cost evaluation technique
through a cross sectional study for a projected period of
9 months. Both qualitative and quantitative approach to
estimate the health care cost of provider and patient’s cost
through microcosting questionnaire method. Patient’s
QOL will be using the locally validated EORTC-QLC-C30
questionnaire. Selected patients from oncologic and surgi-
cal wards, outpatients specialists clinics will be taken as
respondents. Outcomes of study will include cost to treat
a case of SRE and projected country’s burden of SRE from
both cancer. Other outcomes will be compared between
SRE and non-SRE through measurements of cost per
QALYs; cost per life years saved (LYS) and cost per deaths
averted. Associated risk factors will be measured by bivari-
ate and multivariate analyses with power of study of 80%
and p value of 0.05.
Expected result
The cost of treatment among prostate and breast cancer
patient of lower disease compared to those of higher
stages, positive bone metastasis and SRE positive. The
QOL will also be expected to be higher among these
groups. By similar disease stages for each cancer types, the
QOL and costs are expected to be similar.
Conclusion
This information will provide the cost burden of breast
and prostate cancers for the country and will be used for
strategic planning for the country. Patients with risk of
lower QOL will also be identified for better risk assess-
ment during cancer managements.* Correspondence: noraziani17@yahoo.com
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